Your browser doesn't support javascript.
loading
Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials.
Benavides, Manuel; Díaz-Rubio, Eduardo; Carrato, Alfredo; Abad, Albert; Guillén, Carmen; Garcia-Alfonso, Pilar; Gil, Silvia; Cano, María Teresa; Safont, María José; Gravalos, Cristina; Manzano, José Luis; Sánchez, Antonio; Alcaide, Julia; López, Rafael; Massutí, Bartomeu; Sastre, Javier; Martínez, Eva; Escudero, Pilar; Méndez, Miguel; Aranda, Enrique.
Afiliação
  • Benavides M; Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria. IBIMA, Malaga, Spain.
  • Díaz-Rubio E; Medical Oncology Service, Hospital Clínico San Carlos, Madrid, Spain.
  • Carrato A; Ramón y Cajal University Hospital, IRYCIS, CIBERONIC, Alcala University, Madrid, Spain.
  • Abad A; Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Guillén C; Medical Oncology, Hospital Universitario Ramon y Cajal, Madrid, Madrid, Spain.
  • Garcia-Alfonso P; Medical Oncology Service, IRYCIS, Madrid, Comunidad de Madrid, Spain.
  • Gil S; Medical Oncology Service, Hospital General Universitario Gregorio Maranon, Madrid, Spain.
  • Cano MT; Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria. IBIMA, Malaga, Spain.
  • Safont MJ; Medical Oncology Service, Hospital Universitario Reina Sofía, Cordoba, Spain.
  • Gravalos C; Medical Oncology Service, Hospital General Universitario de Valencia, Valencia, Spain.
  • Manzano JL; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Sánchez A; Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Alcaide J; Medical Oncology Service, Hospital Universitario Puerta del Hierro Majadahonda, Madrid, Spain.
  • López R; Medical Oncology Service, Hospital Costa del Sol, Málaga, Spain.
  • Massutí B; Medical Oncology Service, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
  • Sastre J; Medical Oncology Service, Hospital General Universitario de Alicante, Alicante, Spain.
  • Martínez E; Medical Oncology Service, Hospital Clínico San Carlos, Madrid, Spain.
  • Escudero P; Medical Oncology Service, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Méndez M; Medical Oncology Service, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Aranda E; Medical Oncology Service, Hospital Universitario de Móstoles, Madrid, Spain.
ESMO Open ; 4(6): e000599, 2019.
Article em En | MEDLINE | ID: mdl-31803504

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article